Evidence map›Paper›PMID 38618992›Full record

ArticleThe journal of pathology. Clinical research2024

Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the colon.

Malte Gronewold, Isabel Grote, Stephan Bartels, Henriette Christgen, Leonie D Kandt, Maria Jose Brito, Gàbor Cserni, Maximilian E Daemmrich, Franz Fogt, Burkhard M Helmke and 13 more

Open access · goldAbstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 5 countries.

Malte GronewoldInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Isabel GroteInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Stephan BartelsInstitute of Pathology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-8903-2345
Henriette ChristgenInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Leonie D KandtInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Maria Jose BritoPathology and Breast Unit, Champalimaud Foundation, Lisboa, Portugal.
Gàbor CserniDepartment of Pathology, University of Szeged, Szeged, Hungary.
Maximilian E DaemmrichGroup Practice for Pathology Schweinfurt, Schweinfurt, Germany.
Franz FogtPennsylvania Hospital - Penn Pathology and Laboratory Medicine, Philadelphia, PA, USA.
Burkhard M HelmkeElbe Klinikum Stade - Institut für Pathologie, Stade, Germany.
Natalie Ter HoeveDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Corinna Lang-SchwarzKlinikum Bayreuth - Institut für Pathologie, Bayreuth, Germany.
Michael ViethKlinikum Bayreuth - Institut für Pathologie, Bayreuth, Germany.
Axel WellmannInstitute of Pathology Celle, Celle, Germany.
Elna KuehnleClinic for Obstetrics and Gynecology the Neonatology, Hannover Medical School, Hannover, Germany.
Ulf KulikDepartment of General, Visceral, and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Gesa RiedelDepartment of Immunology and Rheumatology, Hannover Medical School, Hannover, Germany.
Tanja Reineke-PlaassInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Ulrich LehmannInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Thijs KoormanDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-6064-3353
Patrick Wb DerksenDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Hans KreipeInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Matthias ChristgenInstitute of Pathology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-0891-7839
Medizinische Hochschule Hannover · DEUniversity Medical Center Utrecht · NLBayreuth Medical Center · DEChampalimaud Foundation · PTElbe Kliniken Stade-Buxtehude · DEInstitute of Pathology Celle · DEPennsylvania Hospital · USTechnical University of Applied Sciences Würzburg-Schweinfurt · DEUniversity of Szeged · HU

Funding

Deutsche Krebshilfe 70112954
6 · The paper itself

Abstract

Invasive lobular carcinoma (ILC) is a special breast cancer type characterized by noncohesive growth and E-cadherin loss. Focal activation of P-cadherin expression in tumor cells that are deficient for E-cadherin occurs in a subset of ILCs. Switching from an E-cadherin deficient to P-cadherin proficient status (EPS) partially restores cell-cell adhesion leading to the formation of cohesive tubular elements. It is unknown what conditions control EPS. Here, we report on EPS in ILC metastases in the large bowel. We reviewed endoscopic colon biopsies and colectomy specimens from a 52-year-old female (index patient) and of 18 additional patients (reference series) diagnosed with metastatic ILC in the colon. EPS was assessed by immunohistochemistry for E-cadherin and P-cadherin. CDH1/E-cadherin mutations were determined by next-generation sequencing. The index patient's colectomy showed transmural metastatic ILC harboring a CDH1/E-cadherin p.Q610* mutation. ILC cells displayed different growth patterns in different anatomic layers of the colon wall. In the tunica muscularis propria and the tela submucosa, ILC cells featured noncohesive growth and were E-cadherin-negative and P-cadherin-negative. However, ILC cells invading the mucosa formed cohesive tubular elements in the intercryptal stroma of the lamina propria mucosae. Inter-cryptal ILC cells switched to a P-cadherin-positive phenotype in this microenvironmental niche. In the reference series, colon mucosa infiltration was evident in 13 of 18 patients, one of which showed intercryptal EPS and conversion to cohesive growth as described in the index patient. The large bowel is a common metastatic site in ILC. In endoscopic colon biopsies, the typical noncohesive growth of ILC may be concealed by microenvironment-induced EPS and conversion to cohesive growth.

Indexed as

Breast NeoplasmsCarcinoma, LobularBiopsyCadherinsColonFemaleHumansMiddle AgedTumor MicroenvironmentCadherinscadherin switchinggrowth patternlobular breast cancertumor‐stroma‐interactionvariants

Identifiers

PMID38618992
PMCPMC10796744
OpenAlexW4391033522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.